je.st
news
Gilead stock hits record after hepatitis C drug's success in Europe
2013-11-22 23:55:24| Biotech - Topix.net
Gilead Sciences said Friday that an advisory committee in the European Union is recommending that its hepatitis C drug Sovaldi receive marketing approval.
Tags: in
stock
record
europe
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||